The use of hair straighteners and chemical relaxers may be associated with a higher incidence of pancreatic cancer, thyroid cancer, and non-Hodgkin’s lymphoma, according to a study.

Reimbursement authority NICE published draft guidance today giving a green light to the use of Columvi (glofitamab) in ...

The survival rate of frozen eggs and embryos reaches more than 90% in good in vitro fertilization labs when a patient is ...

Oral presentation of Lynozyfic™ (linvoseltamab-gcpt) data in newly diagnosed multiple myeloma from LINKER-MM4, the first trial to evaluate a ...

New data from cohort 3 show EO2463 can be safely added to rituximab in first-line low-tumor-burden follicular lymphoma in need of treatment; All six patients responded positively ...

ANTLER phase 1 data demonstrate efficacy and durability on par with autologous CAR-T cell therapy and safety allows for ...

Hodgkin’s Lymphoma. Throughout the month of April, Brett met with the oncologist in Duluth and underwent a bone marrow biopsy ...

Four-time non-Hodgkin lymphoma survivor Shell Rowe knows very well about the importance of finding the lighthearted side of ...

Q3 2025 Earnings Call Transcript November 10, 2025 ADC Therapeutics S.A. beats earnings expectations. Reported EPS is ...

A junior at Flushing High School, Maddie Walker was diagnosed with Primary Mediastinal Large B-Cell Lymphoma, a type of ...

Q3 2025 Earnings Call November 10, 2025 8:30 AM ESTCompany ParticipantsNicole RileyAmeet Mallik - CEO & DirectorMohamed ...

R&D Pipeline -- IND-enabling activities for a PSMA-targeted ADC are on track for completion by year-end, further expanding the development portfolio.